Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M
The all-cash deal is expected to be finalized in April 2026. With this divestment of its ambulatory labs, Tennessee-based Community Health Systems said it will be better able to focus on its core patient care business.
Patient communication AI company receives $65M in funding from private equity
Artera, a company that utilizes AI for patient communications, made the announcement while revealing it has achieved $100 million in annual revenue. Its products use AI for follow-ups after patient care, in addition to supporting clinical decisions.
CVS agrees to pay $38M to resolve insulin over-distribution allegations, DOJ says
Authorities allege the pharmacy chain gave patients more insulin than prescribed and then billed Medicare and Medicaid for the full amounts. This allegedly occurred for more than a decade.
Popular weight-loss drugs don’t tip the scales against Alzheimer’s
Semaglutide alters Alzheimer’s biomarkers but doesn’t slow the disease’s advance.
Abbott acquires cancer diagnostic company Exact Sciences for $21B
The deal will not be finalized until approved by Exact Sciences’ shareholders. With it, Abbott gains control of new diagnostic tools, including a popular at-home test for colorectal cancer.

Some 78% of parents OK with AI reading their child’s chest X-rays

The reception was similarly warm among parents toward AI used to assess a child’s need for antibiotics or bloodwork.

Primary care POCUS on the Old Continent: Guidance needed, but at least 1 use case deemed ‘useful and feasible’

Two European studies illustrate opportunities and challenges presented by the growing appeal of point-of-care ultrasound to primary care practices.

Pulmonary embolism AI cleared

A Silicon Valley AI shop has been OK’d by the FDA to market software that automatically flags suspected pulmonary embolisms (PEs) and immediately notifies physicians.

FDA posts guidance on managing risk of drug shortages

The Food & Drug Administration has drafted guidelines to help U.S. healthcare better prepare for and respond to events associated with these situations.

Claims review may guide evidence-based approach to contrast-shortage mitigation

Iodinated contrast is most widely used in patients undergoing CT studies for, in descending order, abdominopelvic, chest, head/neck and brain indications.

Deep learning model accurately detects COVID-19 on chest X-ray images

Is it pneumonia or COVID-19? With the help of artificial intelligence, a chest X-ray can reveal the answer.

10 clues suggest scope, shape of AI’s future in mammography

Computer-aided detection boosted by AI has often proven superior to traditional CAD over the past decade, yet the “new way” has been slow to win broad adoption.

FDA greenlights expansion of CT-guided, robotically supported IR system

The company says the approval for ablations will allow interventional radiologists to perform these operations with nonlinear steering that facilitates high accuracy and average skin-to-target times under nine minutes.

Business Intelligence

Community Health Systems sells ambulatory diagnostics segment to Labcorp for $194M

Patient communication AI company receives $65M in funding from private equity

CVS agrees to pay $38M to resolve insulin over-distribution allegations, DOJ says

Popular weight-loss drugs don’t tip the scales against Alzheimer’s

Abbott acquires cancer diagnostic company Exact Sciences for $21B